CA2447517A1 - Metered dose inhaler for fluticasone propionate - Google Patents

Metered dose inhaler for fluticasone propionate Download PDF

Info

Publication number
CA2447517A1
CA2447517A1 CA002447517A CA2447517A CA2447517A1 CA 2447517 A1 CA2447517 A1 CA 2447517A1 CA 002447517 A CA002447517 A CA 002447517A CA 2447517 A CA2447517 A CA 2447517A CA 2447517 A1 CA2447517 A1 CA 2447517A1
Authority
CA
Canada
Prior art keywords
metered dose
dose inhaler
fluticasone propionate
fep
excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002447517A
Other languages
French (fr)
Other versions
CA2447517C (en
Inventor
Ian C. Ashurst
Craig S. Herman
Li Li-Bovet
Michael T. Riebe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Smithkline Beecham Corporation
Ian C. Ashurst
Craig S. Herman
Li Li-Bovet
Michael T. Riebe
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32073639&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2447517(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corporation, Ian C. Ashurst, Craig S. Herman, Li Li-Bovet, Michael T. Riebe, Glaxo Wellcome Inc. filed Critical Smithkline Beecham Corporation
Priority claimed from CA002367013A external-priority patent/CA2367013C/en
Publication of CA2447517A1 publication Critical patent/CA2447517A1/en
Application granted granted Critical
Publication of CA2447517C publication Critical patent/CA2447517C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A metered dose inhaler has part or all of its internal surfaces coated with fluorinated ethylene propylene (FEP) and contains an inhalation drug formulation comprising fluticasone propionate or a physiologically acceptable solvate thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
CA002447517A 1995-04-14 1996-04-10 Metered dose inhaler for fluticasone propionate Expired - Lifetime CA2447517C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42211195A 1995-04-14 1995-04-14
US08/422,111 1995-04-14
US58485996A 1996-01-05 1996-01-05
US08/584,859 1996-01-05
CA002367013A CA2367013C (en) 1995-04-14 1996-04-10 Metered dose inhaler for fluticasone propionate

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002367013A Division CA2367013C (en) 1995-04-14 1996-04-10 Metered dose inhaler for fluticasone propionate

Publications (2)

Publication Number Publication Date
CA2447517A1 true CA2447517A1 (en) 1996-10-17
CA2447517C CA2447517C (en) 2006-11-14

Family

ID=32073639

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002447517A Expired - Lifetime CA2447517C (en) 1995-04-14 1996-04-10 Metered dose inhaler for fluticasone propionate

Country Status (1)

Country Link
CA (1) CA2447517C (en)

Also Published As

Publication number Publication date
CA2447517C (en) 2006-11-14

Similar Documents

Publication Publication Date Title
CA2217948A1 (en) Metered dose inhaler for fluticasone propionate
CA2217954A1 (en) Metered dose inhaler for salmeterol
BG102023A (en) Metered dose inhaler for beclomethasone dipropionate
CA2217950A1 (en) Metered dose inhaler for albuterol
EP0995434A3 (en) Medicinal aerosol formulations
WO2001000223A3 (en) Multiple agent diabetes therapy
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
CA2402300A1 (en) Fluorocarbon aerosol medicaments
CA2362499A1 (en) Combinations of formoterol and mometasone furoate for asthma
CA2125666A1 (en) Medicaments
AU4359096A (en) An inhalation device, a method of dispersing a pharmaceutically active substance and a method of administering a dose of pharmaceutically active substance
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
AU3038197A (en) Aerosol formulations
JO2381B1 (en) Formulations containing an antich holinergic drug for the treatment of chronic obstructive pulmonary disease
DE69132407T2 (en) AEROSOL MEDICAL FORMULATIONS
ATE108332T1 (en) ENTERIC FORMULATIONS BASED ON PHYSIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS.
WO2005039481A3 (en) Oral drug delivery system
CA2367013A1 (en) Metered dose inhaler for fluticasone propionate
CA2447517A1 (en) Metered dose inhaler for fluticasone propionate
WO1998009623A3 (en) Use of cholinergic drugs
GEP20002259B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
GEP20002258B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160411